Evaluation of 17 years of MERIN (Meningitis and Encephalitis register in Lower Saxony, Germany) surveillance system: participants acceptability survey, completeness and timeliness of data

• Published in: BMC health services research Vol. 24; no. 1; p. 59
• Main Authors: Łuczyńska, Anna, Beyrer, Konrad, Holle, Ina, Baillot, Armin, Monazahian, Masyar, Dreesman, Johannes, Mertens, Elke, Rettenbacher-Riefler, Sophie
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 11.01.2024; BioMed Central; BMC
• Subjects: Cell culture; Child; Communication; Data collection; Diagnostic tests; Encephalitis; Encephalitis - epidemiology; Enterovirus; Enterovirus Infections - diagnosis; Enterovirus Infections - epidemiology; Evaluation; Germany - epidemiology; Hospital patients; Humans; Laboratories; Meningitis; Meningitis - diagnosis; Meningitis - epidemiology; Pathogens; Pediatrics; Polio-eradication; Poliomyelitis; Poliomyelitis - epidemiology; Population Surveillance - methods; Questionnaires; Sentinel health events; Serology; Statistics; Surveillance; Surveillance equipment; Surveys and Questionnaires; Workloads; Germany; Evaluation; Meningitis; Enterovirus; Surveillance; Polio-eradication
• ISSN: 1472-6963; 1472-6963
• DOI: 10.1186/s12913-023-10482-y

A Meningitis and Encephalitis Surveillance (MERIN) was implemented in 2003 in Lower Saxony, Germany as an alternative to acute flaccid paralyses surveillance, as the latter did not reach WHO sensitivity criteria. The system provides information on circulating enterovirus (EV) serotypes by focussing on patients with suspected aseptic meningitis, encephalitis or acute flaccid paralysis and contributes to the national surveillance in documenting polio free status. MERIN is based on voluntary participation of hospitals. Therefore, our evaluation focusses on acceptability of the system's objectives and performance, and identifying areas for improvement. To assess acceptability, 32 contributing hospitals were invited to an online-based survey (11/2021 to 01/2022) to rate the MERIN objectives, laboratory's performance, their workload, modes of processes and communication. Ideas for improvement were collected in open fields. In addition, data completeness and timeliness of laboratory diagnostics were assessed. Of 32 hospitals, 21 responded (66% response rate), sending 30 questionnaires, 25 from pediatric and 5 from neurological departments. High levels of satisfaction with the communication (≥ 96%), timeliness (≥ 81%), and distribution of the results (≥ 85%) were reported, 97% of participants judged the required workload as adequate. The median proportion of eligible patients included in MERIN was 75%. Participants gave rapid and reliable diagnostic testing the highest priority (96%), while monitoring of Germany's polio-free status was rated the lowest (61%). Providing medical reports digitally as well as regular updates about circulating EV serotypes were identified as areas for improvement. Data completeness of selected variables ranged from 78.3 to 99.9%. Median time between sample collection and arrival at laboratory was 2 days [IQR 1-3], EV diagnostics via PCR took one day [IQR 0-6] and EV isolation on cell culture 11 days [IQR 10-13]. MERIN is a highly accepted surveillance system. Its quality was enhanced further by addressing the suggested improvements such as regular reports on circulating EV serotypes and facilitating digital access to laboratory results. Our results emphasise the importance of recognizing and considering participants' motivations and expectations, and addressing their priorities, even if this is not the surveillance system's main focus. This approach can be applied to surveillance systems of other non-mandatory notifiable diseases.